Brian Buck
Overview
Explore the profile of Brian Buck including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
1187
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goyal M, Menon B, Ospel J, Almekhlafi M, Zerna C, Nogueira R, et al.
J Stroke
. 2025 Feb;
27(1):95-101.
PMID: 39916458
Background And Purpose: In the ESCAPE-NA1 (Efficacy and Safety of Nerinetide for the Treatment of Acute Ischaemic Stroke) trial, treatment with nerinetide was associated with improved outcomes in patients who...
2.
Helbitz A, Haris M, Younsi T, Romer E, Ginks W, Raveendra K, et al.
Heart Rhythm
. 2025 Jan;
PMID: 39864482
Background: Detecting atrial fibrillation (AF) after stroke is a key component of secondary prevention, but indiscriminate prolonged cardiac monitoring is costly and burdensome. Multivariable prediction models could be used to...
3.
Uchida K, Bosshart S, Stebner A, Almekhlafi M, Demchuk A, Ganesh A, et al.
J Neurol Sci
. 2024 Nov;
467:123316.
PMID: 39580929
Background: Carotid plaques may be an important etiology in ischemic stroke. We aimed to assess carotid plaque characteristics ipsilateral and contralateral to the ischemic stroke and assessed the prevalence of...
4.
Sarmiento R, Wagner A, Sheriff A, Taralson C, Moniz N, Opsahl J, et al.
NeuroSci
. 2024 Nov;
5(3):291-300.
PMID: 39483280
The burden of simultaneous acute code stroke activation (ACSA) is not known. We aim to assess the effect of simultaneous ACSA on workflow metrics and home time at 90 days...
5.
Stebner A, Bosshart S, Demchuk A, Poppe A, Nogueira R, McTaggart R, et al.
Clin Neuroradiol
. 2024 Oct;
35(1):141-150.
PMID: 39404848
Purpose: The modified Rankin Scale (mRS) at 90 days is the primary outcome in most acute stroke studies, but the long follow-up period has disadvantages. The National Institutes of Health...
6.
Ospel J, Dowlatshahi D, Demchuk A, Volders D, Mohlenbruch M, Nimjee S, et al.
Int J Stroke
. 2024 Jun;
19(9):1064-1070.
PMID: 38845180
Rationale: Clinical outcomes in acute ischemic stroke due to medium vessel occlusion (MeVO) are often poor when treated with best medical management. Data from non-randomized studies suggest that endovascular treatment...
7.
Bala F, Singh N, Ignacio K, Alhabli I, Ademola A, Alrohimi A, et al.
J Stroke
. 2024 Jun;
26(2):280-289.
PMID: 38836275
Background And Purpose: The safety and efficacy of tenecteplase in patients with ischemic stroke due to medium vessel occlusion (MeVO) are not well studied. We aimed to compare tenecteplase with...
8.
Tanaka K, Kaveeta C, Pensato U, Zhang J, Bala F, Alhabli I, et al.
Stroke
. 2024 May;
55(7):1758-1766.
PMID: 38785076
Background: Early ischemic change and collateral extent are colinear with ischemic core volume (ICV). We investigated the relationship between a combined score using the Alberta Stroke Program Early Computed Tomography...
9.
Levkowitz E, Gibson R, Xu H, Zhang L, Eskine K, Buck B, et al.
Pediatr Emerg Care
. 2024 May;
41(1):11-16.
PMID: 38718803
Objective: We investigated the diagnostic value of shock index, pediatric age-adjusted (SIPA) in predicting Emergency Severity Index level 3 patients' outcomes. Secondary objectives included exploring the impact of fever and...
10.
Singh N, Kenney C, Butcher K, Buck B, Barber P, Field T, et al.
Int J Stroke
. 2024 Apr;
19(7):817-822.
PMID: 38676572
Background: Almost half of acute ischemic stroke patients present with mild symptoms and there are large practice variations in their treatment globally. Individuals with an intracranial occlusion who present with...